Medovent Overview

  • Founded
  • 2006
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Medovent General Information


Developer of chitin and chitosan based polymers designed to offer flexible and long-term stable nerve growth. The company's products actively regenerates nerve fibers, enabling users to get protection against tissue ingrowth and scarring.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Therapeutic Devices
Other Devices and Supplies
Primary Office
  • Friedrich-Koenig-Strasse 3
  • 55129 Mainz
  • Germany
+49 06131 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medovent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 31-Oct-2018 Completed Generating Revenue
4. Early Stage VC 01-May-2010 Completed Startup
3. Early Stage VC 01-Jun-2008 Completed Startup
2. Seed Round 01-Oct-2006 Completed Startup
1. Grant Completed Startup
To view Medovent’s complete valuation and funding history, request access »

Medovent Executive Team (5)

Name Title Board Seat Contact Info
Dougal Bendjaballah Managing Director
You’re viewing 1 of 5 executive team members. Get the full list »

Medovent Board Members (3)

Name Representing Role Since
Cathrin Pauly Self Supervisory Board Member 000 0000
Karsten Henco Ph.D HS LifeSciences Member of Supervisory Board 000 0000
Wolfgang Riehle Self Supervisory Board Member & Chairman of Advisory Board 000 0000
To view Medovent’s complete board members history, request access »

Medovent Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Investitions- und Strukturbank Rheinland-Pfalz Venture Capital Minority 000 0000 000000 0
HS LifeSciences Venture Capital Minority 000 0000 000000 0
European Regional Development Fund Other 000 0000 000000 0
To view Medovent’s complete investors history, request access »